Trials / Recruiting
RecruitingNCT07117864
Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- QIAO LI · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A study on the safety and efficacy of T-DXd in combination with local radiotherapy for brain metastases in HER2-Positive and HER2-Low breast cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | T-DXd concurrent brain radiotherapy | T-DXd：5.4mg/kg ivgtt Q3w SRT/WBRT |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
- First posted
- 2025-08-12
- Last updated
- 2025-08-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07117864. Inclusion in this directory is not an endorsement.